Heterogeneity in hepatitis C treatment prescribing and uptake in Australia: a geospatial analysis of a year of unrestricted treatment access

BACKGROUND AND AIM: Direct-acting antiviral (DAA) treatments became available for all people living with hepatitis C virus (HCV) in Australia in March 2016. We assess variations in treatment rates and prescribing patterns across Australia's 338 Statistical Area 3 (SA3) geographical units. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales: Scott, Nick, Hainsworth, Samuel W, Sacks-Davis, Rachel, Pedrana, Alisa, Doyle, Joseph, Wade, Amanda, Hellard, Margaret
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mediscript Ltd 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5892674/
https://www.ncbi.nlm.nih.gov/pubmed/29682303

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5892674/
https://www.ncbi.nlm.nih.gov/pubmed/29682303

Ejemplares similares